Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 18Chronic Kidney Disease and DiabetesAdvanced Glycation End Products researchDiabetes Management and Research

The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.

A comparative analysis of fructosamine with other risk factors for kidney dysfunction in diabetic patients with or without chronic kidney disease

Neelofar, Km, Ahmad, Jamal·2019·Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Abstract

BACKGROUND Hyperglycemia is the driving force for the development of diabetic nephropathy leading to the end stage renal disease. It is well known that in hyperglycaemic condition, serum proteins become glycated through non-enzymatic glycation. With the other risk factors, serum fructosamine may be an important risk factor for kidney impairment. To assess coexistence of frequently documented risk factors of kidney dysfunction with serum fructosamine in diabetic patients with chronic kidney disease (CKD). METHODS In this study, total 150 individuals, as control, type2 diabetic patients without complication and with CKD were included. Blood samples were collected from all the samples to estimate blood glucose, HbA1c, serum creatinine, fructosamine levels and lipid profile. Statistical analysis i.e. regression and correlation between serum fructosamine and other documented risk factors for diabetic CKD has been done. P < 0.001 was considered significant. RESULTS Serum fructosamine, HbA1c, creatinine levels, cholesterol and LDL were increased significantly (P < 0.001) in diabetic patients with CKD compared to without complications. Systolic and diastolic blood pressure and BMI were also significantly higher in diabetic patients compared to control. Serum creatinine, total cholesterol and LDL showed a significant positive correlation but HDL showed a negative correlation with fructosamine in CKD diabetic patients. No significant correlation was found with any risk factors in diabe…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.dsx.2018.08.007

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 17 references

Research works printed but not linked: 1

  1. 2012, American diabetes association, Diabetes Care, 351, 64

Cited by

Metadata

Authors
Neelofar, K., & Ahmad, J.
Affiliations
Aligarh Muslim University (IN)
Corresponding author
Neelofar, Km
Venue
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Publisher
Elsevier BV
Published
2019-01
Volume
13
Issue
1
Pages
240-244
ISSN
1871-4021 (ISSN-L)
OpenAlex
W2885754046
Cited by
18
References
17
Citations by year
2025: 1 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 1
FWCI
1.65
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes & Metabolic Syndrome Clinical Research & Reviews (publishedVersion)
  • PubMed (publishedVersion)
Funders
ICMR, New Delhi
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
fructosamine, chronic kidney disease, diabetic nephropathy, renal dysfunction, glycation, hyperglycemia, HbA1c, serum creatinine, lipid profile, blood pressure, body mass index, risk factors
MeSH terms
Adult, Aged, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prognosis, Risk Factors, Biomarkers, Case-Control Studies, Fructosamine, Renal Insufficiency, Chronic, Renal Insufficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.